查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
2022-2029 年鼻插管的全球市场
市场调查报告书
商品编码
1166509

2022-2029 年鼻插管的全球市场

Global Nasal Cannula Market - 2022-2029
出版日期: | 出版商: DataM Intelligence | 英文 200 Pages | 商品交期: 约2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

市场概览

预计2022年全球鼻插管市场规模将达到63.8761亿美元，2029年将达到100.8539亿美元，预测期内（2022-2029年）复合年增长率为5.84%。据说

鼻插管是一种医疗器械，可为患有呼吸系统疾病的患者提供高气流或补充氧气。 该设备可改善氧气输送并提供更好的通风。 它由一根管子组成，管子的一端有两个尖头，氧气从中流过。

市场动态

由于哮喘、慢性阻塞性肺病和肺炎等呼吸系统疾病的发病率增加、技术进步和新产品的推出，推动全球鼻插管市场的主要因素是鼻插管需求的增加。

研发投资的增加和新技术的进步预计将推动市场的增长。

鼻插管市场受到最新技术的推动，同时技术进步不断增加、老年人口不断增加、研发投资激增、哮喘和慢性阻塞性肺病等呼吸系统疾病不断增加，以及新兴市场医疗基础设施的改善。新产品改进推动了鼻插管市场的发展.

鼻插管用于为呼吸系统疾病患者提供补充氧气。 由于 COVID，政府启动了各种基金和举措，以满足对鼻插管等必要产品的需求。 这些资金将用于生产所有基本保健产品。 由于呼吸系统疾病的增加，这些应用的市场正在全球范围内扩大。 此外，预计主要参与者提供的技术先进的产品也将在市场增长中发挥重要作用。

各种新产品的发布和研究正在为市场的增长做出贡献。 例如，2022 年 5 月，急慢性呼吸护理和产品提供商 Fisher & Paykel Healthcare Corporation 宣布推出 Airvo 3 高流量系统。 该设备提供比提供 Optiflow 疗法的 Airvo 2 更先进的技术。 有针对性的氧气输送配备了 OptiO2 闭环系统，可提供准确的氧气浓度。 这个最先进的系统还包括一个内置电池和一个大触摸屏界面。

与鼻插管相关的副作用预计会阻碍市场增长。

鼻插管使用后的各种副作用，如咽干、鼻干、眼睛刺激、胃胀、面罩不适、鼻眼外伤，有时还会流鼻血等，是阻碍鼻插管市场增长的一大因素.

长期吸氧会因肺氧中毒导致眼部损伤和肺部损伤，肺部氧中毒会因高压升高而损害肺部和眼睛。 此外，中枢神经系统高压的累积会导致严重的并发症，例如健忘症，影响多个器官。 严格的监管也是抑制市场增长的关键因素。

COVID-19 影响分析

疫情对全球金融预期、运营和危机应对策略产生了积极影响。 COVID-19 的爆发严重影响了医疗保健行业。 由于病毒导致对这些鼻插管的需求，呼吸道疾病的发病率有所增加，因此鼻插管市场因 COVID 而获得了巨大收益。 主要製造商已经启动了各种研究和临床试验。 世界各地正在发生各种举措、产品发布、合作和合併，推动市场增长。 例如，2022 年 11 月，Hamilton Medical 宣布 HAMILTON-C3 呼吸机可以在通气或高流量氧疗之间切换。 HAMILTON-C3 提供 60 l/min 的流速。 仅应更改通气模式和患者界面。

内容

第1章研究方法与范围

  • 调查方法
  • 调查目的和范围

第 2 章市场定义和概述

第 3 章执行摘要

第四章市场动态

  • 市场影响因素
    • 司机
      • 增加研发投资
      • 不断进步的技术进步
    • 约束因素
      • 与鼻插管相关的副作用
    • 商机
    • 影响分析

第5章行业分析

  • 波特的五力分析
  • 供应链分析
  • 定价分析
  • 监管分析

第 6 章 COVID-19 分析

  • COVID-19 市场分析
    • COVID-19 之前的市场情景
    • COVID-19 的当前市场情景
    • COVID-19 后或未来情景
  • COVID-19 期间的价格动态
  • 供需范围
  • 大流行期间与市场相关的政府举措
  • 製造商的战略举措
  • 总结

第 7 章按类型

  • 高流量鼻插管
  • 低流量鼻插管

第 8 章按爪形

  • 弧形和喇叭形叉脚
  • 弯曲的叉子
  • 喇叭形爪
  • 直叉

第9章材料

  • 聚氯乙烯
  • 硅胶
  • 其他

第 10 章应用

  • 支气管哮喘
  • 慢性阻塞性肺疾病
  • 囊性纤维化
  • 睡眠呼吸暂停综合症
  • 肺炎
  • 心血管外科
  • 糖尿病治疗
  • 其他

第 11 章最终用户

  • 医院
  • 门诊手术中心
  • 新生儿重症监护病房
  • 家庭护理
  • 其他

第12章按地区

  • 北美
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 意大利
    • 西班牙
    • 其他欧洲
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他南美洲
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 澳大利亚
    • 其他亚太地区
  • 中东和非洲

第13章竞争格局

  • 主要发展和战略
  • 公司股票分析
  • 产品基准
  • 值得关注的主要公司名单

第14章公司简介

  • 史密斯医疗（ICU 医疗）
    • 公司概况
    • 产品组合和说明
    • 主要亮点
    • 财务摘要
  • Teleflex Inc.
  • Medline Industries Inc.
  • Hamilton Medicals
  • Neotech Products
  • Medin Medical Innovations GmbH
  • Flexicare Ltd.
  • Fairmont Medical
  • Fisher & Paykel Healthcare Limited
  • Sunset Healthcare Solutions Inc.

第15章 全球鼻插管市场-DataM

简介目录
Product Code: DMMD1199

Market Overview

The global nasal cannula market size was valued at US$ 6,387.61 million in 2022 and is estimated to reach US$ 10,085.39 million by 2029, growing at a CAGR of 5.84% during the forecast period (2022-2029).

The nasal cannula is a medical device that provides high airflow or supplemental oxygen to patients with respiratory disorders. This device improves oxygenation and provides better ventilation. It consists of a tube that splits into two prongs at one end from which the oxygen flows.

Market Dynamics

The major factors driving the global nasal cannula market are the rising demand for nasal cannulas owing to increasing incidences of respiratory disorders such as asthma, COPD, and pneumonia, technological advancements and novel product launches.

The increasing research and development investments and novel technological advancements are expected to drive the market's growth.

The nasal cannula market is driven by rising advancements in technology, an increase in the geriatric population, a surge in research and development investments, an increasing number of respiratory disorders such as asthma and COPD, and improvements in novel products using the latest technology along with improvements in medical infrastructure in emerging markets.

The nasal cannula is used for providing supplemental oxygen to breathing disorder patients. Due to COVID, the government started various funds and initiatives to meet the demand for the required product, such as a nasal cannula. These funds will help in the production of all essential healthcare products. The market for these applications is increasing worldwide due to the enhanced number of respiratory disorders. Moreover, the availability of technologically advanced products by key players is also expected to play a vital role in the market's growth.

Various novel product launches and research studies contribute to the market's growth. For instance, in May 2022, Fisher & Paykel Healthcare Corporation, an acute and chronic respiratory care and products provider, announced its Airvo 3 high-flow system's release. This device provides more advanced technology than Airvo 2, which delivers Optiflow therapy. For targeted oxygen delivery, it has an OptiO2 closed-loop system that delivers an accurate oxygen level. An integrated battery and a large touchscreen interface are also included in this latest system.

Side effects associated with nasal cannulas are expected to hamper the market's growth.

Various side effects after using nasal cannulas, such as dry throat, nasal dryness, eye irritation, gastric distension, mask discomfort, nasal and eye trauma and sometimes bleeding nose, are the major factor hindering the growth of the nasal cannula market.

Long-term supplemental oxygen usage may result in eye damage or lung damage due to pulmonary oxygen toxicity, a condition in which high-pressure build-up causes damage to the lungs or eyes. It can even cause severe complications such as amnesia due to high-pressure build-up in the CNS and can affect multiple organs. Stringent regulations are also a key factor hindering the growth of the market.

COVID-19 Impact Analysis

The pandemic has positively impacted global financial expectations, operations and crisis response strategy. The COVID-19 outbreak has severely impacted the healthcare industry. The nasal cannula market has experienced huge profits due to COVID, as the incidence of respiratory disorders increased due to the virus leading to demand these nasal cannulas. Key manufacturers have started various research and clinical trials. Various initiatives, product launches, collaborations and mergers are happening worldwide, boosting the market's growth. For instance, in Nov 2022, Hamilton Medical announced that its HAMILTON-C3 Ventilator could be switched between ventilation or high-flow oxygen therapy. HAMILTON-C3 provides 60 liters/minute flow rate. Only the mode of ventilation and patient interface is needed to be changed.

Segment Analysis

The high-flow nasal cannula-type segment is expected to grow at the fastest CAGR during the forecast period (2022-2029)

The type segment is the highest market holder in the global nasal cannula market. The global nasal cannula market is segmented based on type as a high-flow nasal cannula and low-flow nasal cannula. The high-flow nasal cannula segment is the largest market shareholder due to its inherent advantages over low-flow cannulas, increasing technological advancements and novel product launches.

The high-flow nasal cannula is a non-invasive respiratory help. This oxygen system delivers around 100% heated and humidified oxygen at approximately 60 liters per minute flow rate. The high-flow cannulas settings are independent and provide better outcomes and high confidence and control when used in supplemental oxygen delivery. High-flow nasal cannulas have various benefits, as humidified and heated oxygen decreases airway inflammation and energy expenditure.

The growing number of regulatory approvals, technological advancements, product launches, and research/clinical trial studies drive the market's growth. For instance, in May 2022, Fisher & Paykel Healthcare Corporation Limited, an acute and chronic respiratory care products provider, announced the launch of its products Optiflow Switch and Optiflow Trace, two latest nasal high-flow interfaces specially designed for applications in anesthesia. These will expand Optiflow nasal high-flow's market opportunity within the company's respiratory segment. The optiflow Switch interface is developed for anesthesia and provides high-humidified oxygen flow. The Optiflow Trace interface is used for the sedation procedure that provides high humidified oxygen flow and samples the expired CO2.

Geographical Analysis

North America holds the largest market share in the global nasal cannula market.

North America dominates the global nasal cannula market primarily due to its large population, excellent medical infrastructure, and high-income levels. The market is expected to grow at a relatively moderate pace during the forecast period due to healthcare expenditure in the US. The market's significant size is attributed to the high medical expenditure.

Increasing expenditure on healthcare and raising awareness among people are also contributing to the market's growth in this region. Advancement of applications of the nasal cannula in several respiratory diseases or surgical procedures, increase in pharmaceutical establishment across the region and government approvals, and the presence of key players in the region are contributing to the growth of the nasal cannula market.

Moreover, the growing number of product launches is responsible for the market's growth. Many key developments, technological advancements, collaborations, and agreements are taking place in this region. For instance, in Dec 2021, Sunset Healthcare Solutions, a respiratory and medical equipment supplier, announced its partnership with Vizient Supply LLC.

Competitive Landscape

The nasal cannula market is moderately competitive with local and global companies' presence. Smith's Medical (ICU Medical), Teleflex Inc., Medline Industries Inc., Hamilton Medicals, Neotech Products, Medin Medical Innovations GmbH, Flexicare Ltd., Fairmont Medical, Fisher & Paykel Healthcare Limited, Sunset Healthcare Solutions Inc. and more. The key players are adopting various growth strategies such as product launches, mergers & acquisitions, partnerships, and collaborations, contributing to the market's growth. For instance, in October 2022, Medline announced its multi-year vendor partnership with Hoag Memorial Hospital Presbyterian health system to provide essential medical supplies portfolio to the acute and non-acute care network.

Smith's Medical (ICU Medical).

Overview: Smith's Medical, now a part of ICU Medical, is a developer and manufacturer of innovative medical products used in vital care applications. Established in 1940 and is headquartered in Minnesota, United States.

Product Portfolio:

Portex First Breath: This nasal cannula provides O2 in low and medium concentrations, with flared or non-flared tips. It can be used for adults, neonatal, as well as pediatrics.

Key Development: In Jan 2022, ICU Medical Inc. announced its acquisition of Smith's Medical. Adding vital care products to the ICU portfolio.

The global nasal cannula market report would provide access to approx.: 45+market data table, 40+figures and 200 (approximate) pages.

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Market Definition and Overview

3. Executive Summary

4. Market Dynamics

  • 4.1. Market Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Increasing research and development investments
      • 4.1.1.2. Rising technological advancements
    • 4.1.2. Restraints:
      • 4.1.2.1. Side effects associated with nasal cannula
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1 Porter's Five Forces Analysis
  • 5.2 Supply Chain Analysis
  • 5.3 Pricing Analysis
  • 5.4 Regulatory Analysis

6. COVID-19 Analysis

  • 6.1. Analysis of Covid-19 on the Market
    • 6.1.1. Before COVID-19 Market Scenario
    • 6.1.2. Present COVID-19 Market Scenario
    • 6.1.3. After COVID-19 or Future Scenario
  • 6.2. Pricing Dynamics Amid Covid-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During the Pandemic
  • 6.5. Manufacturer's Strategic Initiatives
  • 6.6. Conclusion

7. By Type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 7.1.2. Market Attractiveness Index, By Type
  • 7.2. High Flow Nasal Cannula*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 7.3. Low Flow Nasal Cannula

8. By Prong Shape

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Prong Shape
    • 8.1.2. Market Attractiveness Index, By Prong Shape
  • 8.2. Curved and Flared Prongs *
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 8.3. Curved Prongs
  • 8.4. Flared Prongs
  • 8.5. Straight Prongs

9. By Material

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
    • 9.1.2. Market Attractiveness Index, By Material
  • 9.2. PVC *
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 9.3. Silicone
  • 9.4. Others

10. By Application

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.1.2. Market Attractiveness Index, By Application
  • 10.2. Asthma *
    • 10.2.1. Introduction
    • 10.2.2. Market Size Analysis US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 10.3. COPD
  • 10.4. Cystic Fibrosis
  • 10.5. Sleep Apnea
  • 10.6. Pneumonia
  • 10.7. Cardiovascular Surgery
  • 10.8. Diabetes Treatment
  • 10.9. Others

11. By End-User

  • 11.1. Introduction
    • 11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 11.1.2. Market Attractiveness Index, By End-User
  • 11.2. Hospitals *
    • 11.2.1. Introduction
    • 11.2.2. Market Size Analysis US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 11.3. Ambulatory Surgical Centers
  • 11.4. Neonatal Intensive Care Units
  • 11.5. Home Care Setting
  • 11.6. Others

12. By Region

  • 12.1. Introduction
    • 12.1.1. Market Size Analysis US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029, By Region
    • 12.1.2. Market Attractiveness Index, By Region
  • 12.2. North America
    • 12.2.1. Introduction
    • 12.2.2. Key Region-Specific Dynamics
    • 12.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 12.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Prong Shape
    • 12.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
    • 12.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 12.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 12.2.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 12.2.8.1. U.S.
      • 12.2.8.2. Canada
      • 12.2.8.3. Mexico
  • 12.3. Europe
    • 12.3.1. Introduction
    • 12.3.2. Key Region-Specific Dynamics
    • 12.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 12.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Prong Shape
    • 12.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
    • 12.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 12.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 12.3.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 12.3.8.1. Germany
      • 12.3.8.2. U.K.
      • 12.3.8.3. France
      • 12.3.8.4. Italy
      • 12.3.8.5. Spain
      • 12.3.8.6. Rest of Europe
  • 12.4. South America
    • 12.4.1. Introduction
    • 12.4.2. Key Region-Specific Dynamics
    • 12.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 12.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Prong Shape
    • 12.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
    • 12.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 12.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 12.4.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 12.4.8.1. Brazil
      • 12.4.8.2. Argentina
      • 12.4.8.3. Rest of South America
  • 12.5. Asia Pacific
    • 12.5.1. Introduction
    • 12.5.2. Key Region-Specific Dynamics
    • 12.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 12.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Prong Shape
    • 12.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
    • 12.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 12.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 12.5.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 12.5.8.1. China
      • 12.5.8.2. India
      • 12.5.8.3. Japan
      • 12.5.8.4. Australia
      • 12.5.8.5. Rest of Asia Pacific
  • 12.6. Middle East and Africa
    • 12.6.1. Introduction
    • 12.6.2. Key Region-Specific Dynamics
    • 12.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 12.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Prong Shape
    • 12.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
    • 12.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 12.6.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

13. Competitive Landscape

  • 13.1. Key Developments and Strategies
  • 13.2. Company Share Analysis
  • 13.3. Products Benchmarking
  • 13.4. List of Key Companies to Watch

14. Company Profiles

  • 14.1. Smith's Medical (ICU Medical) *
    • 14.1.1. Company Overview
    • 14.1.2. Product Portfolio and Description
    • 14.1.3. Key Highlights
    • 14.1.4. Financial Overview
  • 14.2. Teleflex Inc.
  • 14.3. Medline Industries Inc.
  • 14.4. Hamilton Medicals
  • 14.5. Neotech Products
  • 14.6. Medin Medical Innovations GmbH
  • 14.7. Flexicare Ltd.
  • 14.8. Fairmont Medical
  • 14.9. Fisher & Paykel Healthcare Limited
  • 14.10. Sunset Healthcare Solutions Inc.

LIST NOT EXHAUSTIVE

15. Global Nasal Cannula Market - DataM

  • 15.1. Appendix
  • 15.2. About Us and Application
  • 15.3. Contact Us